Regulatory Explainer

503A vs. 503B compounding pharmacies: what clinics need to know

📅 Last updated: April 2026 ⏱ 8 min read

Two categories, two completely different sets of rules. Getting this wrong is one of the most common compliance mistakes clinic operators make when sourcing compounded therapies.

The short version

503A pharmacies are traditional compounding pharmacies. They make medications for individual patients based on a valid prescription. They're licensed by state boards of pharmacy and follow USP standards.

503B facilities are FDA-registered outsourcing facilities. They can produce medications in bulk without patient-specific prescriptions, allowing office-use dispensing. They're subject to federal Current Good Manufacturing Practice (cGMP) standards — the same standards drug manufacturers follow.

The key distinction in one sentence

503A = patient-specific prescriptions, state-regulated. 503B = bulk production without prescription, FDA-regulated with stricter manufacturing standards.

Detailed comparison

Factor 503A (Traditional) 503B (Outsourcing Facility)
Governing body State Board of Pharmacy
+ limited FDA oversight
FDA (federal)
+ State Board of Pharmacy
Prescription required? Yes — patient-specific Rx for each compound No — can produce in bulk for office stock
Manufacturing standard USP 795/797/800 standards cGMP (federal drug manufacturer standards)
FDA inspections Generally not routinely inspected Registered with FDA, subject to inspection
Patient populations Individual identified patients only Can produce for any licensed prescriber
Office stock dispensing Generally not permitted (state-dependent) Permitted — clinics can maintain inventory
GLP-1 compounding Patient-specific Rx only, during shortage Permitted with documented clinical rationale
Pricing model Per-prescription, typically higher unit cost Bulk pricing, lower per-unit cost

When does your clinic need each?

The right choice depends on how your clinic operates — specifically, how you prescribe and dispense.

Use a 503A pharmacy when:
  • You write individual prescriptions for each patient
  • You want maximum customization (unique dosage, delivery form)
  • Your state allows traditional compounding for your therapy type
  • You're sourcing specialty HRT formulations with specific patient needs
  • You need novel or rarely-used combinations not available from 503B
Use a 503B facility when:
  • You want to maintain in-clinic medication inventory
  • You're administering injections in-office (GLP-1, peptides)
  • You need high-volume, consistent supply with cGMP quality assurance
  • You want formal FDA oversight and regular inspection records
  • Your legal or malpractice counsel recommends documented federal oversight

⚠️ Can you use both?

Yes — and many practices do. A clinic might source GLP-1 vials from a 503B for in-office administration while using a 503A for customized HRT formulations. Each relationship requires separate verification, licensing review, and BAAs. Veridian's network includes both types with pre-verified credentials.

Licensing requirements by pharmacy type

For 503A pharmacies, verify:

Before sourcing from any 503A pharmacy, confirm these are current and valid:

  • State pharmacy board license (active, no restrictions)
  • NABP e-profile (accreditation status)
  • PCAB accreditation (voluntary but credibility signal)
  • Most recent USP 795/797 compliance review date
  • Licensed in your state (must hold license in states where prescriptions originate)

For 503B facilities, verify:

  • Active FDA registration as an outsourcing facility (searchable at FDA.gov)
  • No FDA Warning Letters or import alerts (check FDA Enforcement Actions database)
  • cGMP inspection history (FDA publishes inspection reports)
  • Certificate of Analysis (CoA) available for each batch
  • State distribution license in your state

Common myths, corrected

"503B is always safer than 503A"

Not necessarily. 503B facilities face stricter manufacturing oversight, but their compounds are still unapproved drugs. Both types can have quality issues. What matters is your vetting process, not just the category.

"Any licensed pharmacy can compound GLP-1s now"

No — semaglutide was removed from the FDA shortage list in early 2025. Compounding rules changed significantly. See our GLP-1 Regulatory Status page for current guidance.

"I don't need a BAA with my compounding pharmacy"

Wrong. Compounding pharmacies handle protected health information (PHI) to fill prescriptions. A HIPAA Business Associate Agreement is required. See our HIPAA BAA page for details.

Disclaimer: This information is for educational purposes only and does not constitute legal or medical advice. Compounding pharmacy regulations vary by state and are subject to change. Consult a healthcare attorney for guidance specific to your practice and jurisdiction. Last updated: April 2026.

Veridian's licensed pharmacy network is continuously monitored for compliance

Both 503A and 503B options in our network are verified for licensing, accreditation, and BAA readiness before you can access them.

Apply for Access →

Weekly From Veridian

Compliance updates. Formulary changes.
Clinic growth strategies.

One email a week. Useful every time. Unsubscribe whenever.

Join clinic operators staying current on compounding compliance and GLP-1 sourcing.